Clinical trial
Helium-Hyperoxia and 6MWT Distance in COPD
NCT00394225 · University of Saskatchewan, Other · Completed
Key facts
| NCT number | NCT00394225 |
|---|---|
| Title | Helium-Hyperoxia and 6MWT Distance in COPD |
| Official title | The Effects of Helium-Hyperoxia on 6-Minute Walking Distance in Chronic Obstructive Pulmonary Disease - A Randomized, Controlled Trial |
| Lead sponsor | University of Saskatchewan, Other |
| Collaborators | Nova Scotia Health Authority |
| Status | Completed |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | Oxygen, Helium |
| Enrollment | 16 |
| Start date | Jul 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Oct 31, 2006 |
| Last update posted | Oct 31, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: